An Evidence-Based Review of Fremanezumab for the Treatment of Migraine-Reference-Cited by-同舟云学术

An Evidence-Based Review of Fremanezumab for the Treatment of Migraine

Published:2020-03-28 Issue:1 Volume:9 Page:195-215
ISSN:2193-8237
Container-title:Pain and Therapy
language:en
Short-container-title:Pain Ther

Author:

Urits Ivan,Clark Gavin,An Daniel,Wesp Bredan,Zhou Rebecca,Amgalan Ariunzaya,Berger Amnon A.,Kassem Hisham,Ngo Anh L.,Kaye Alan D.,Kaye Rachel J.,Cornett Elyse M.,Viswanath Omar

Publisher

Springer Science and Business Media LLC

Subject

Anesthesiology and Pain Medicine,Neurology (clinical)

Link

http://link.springer.com/content/pdf/10.1007/s40122-020-00159-3.pdf

Reference133 articles.

1. Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1–211. https://doi.org/10.1177/0333102417738202.

2. Quintela E, Castillo J, Muñoz P, Pascual J. Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia. 2006;26(9):1051–60.

3. Viana M, Sances G, Ghiotto N, Guaschino E, Allena M, Nappi G, Goadsby P, Tassorelli C. Variability of the characteristics of a migraine attack within patients. Cephalalgia. 2016;36(9):825–30.

4. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease study 2016. Lancet Neurol. 2018;17(11):954–76. https://doi.org/10.1016/S1474-4422(18)30322-3.

5. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache. 2008;48(8):1157–68.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genistein mitigates nitroglycerine-induced migraine: modulation of nitric oxide-mediated vasodilation and oxidative stress;Metabolic Brain Disease;2024-05-25

2. Prevalence and burden of migraine in the United States: A systematic review;Headache: The Journal of Head and Face Pain;2024-05

3. Migraine and Its Treatment from the Medicinal Chemistry Perspective;ACS Pharmacology & Translational Science;2024-03-16

4. Impact of anti-CGRP monoclonal antibodies on central sensitization level in migraine patients;Medical alphabet;2024-01-19

5. Efficacy and Safety of Anti-calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibodies in Preventing Migraines: A Systematic Review;Cureus;2023-09-19